Association of three single nucleotide polymorphisms of the E-cadherin gene with endometriosis in a Chinese population

Reproduction

Volumn 134, Issue 2, 2007, Pages 373-378

  Kang, Shan ^a   Ma, Xiao Wei ^a   Na, Wang ^a   Zhang, Xiu Feng ^a   Wen, Deng Gui ^b   Guo, Wei ^a   Zhang, Zheng Mao ^a   Li, Yan ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b Hebei Cancer Institute   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; CYTOSINE; DNA; GUANINE; THYMINE; UVOMORULIN;

3' UNTRANSLATED REGION; ADULT; AMINO ACID SUBSTITUTION; ARTICLE; BLOOD SAMPLING; CHINESE; CONTROLLED STUDY; DNA EXTRACTION; ENDOMETRIOSIS; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PATHOGENESIS; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CADHERINS; CASE-CONTROL STUDIES; CHINA; CONFIDENCE INTERVALS; ENDOMETRIOSIS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); RISK;

EID: 34548036500     PISSN: 14701626     EISSN: None     Source Type: Journal    
DOI: 10.1530/REP-07-0104     Document Type: Article

References (34)

1. Becker KF, Reich U, Schott C & Hofler H 1995 Single superoxide nucleotide polymorphisms in the human E-cadherin gene. Human Genetics 96 739-740.
2. Behrens J, Lowrick O, Klein-hitpass L & Birchmeier W 1991 The E-cadherin promoter: Functional analysis of a G-C-rich region and an epithelial cell-specific palindromic regulatory element. PNAS 88 11495-11499.
3. Birchmeier W & Behrens J 1994 Cadherin expression in carcinomas: Role in the formation of cell junctions and the prevention of invasiveness. Biochimica et Biophysica Acta 27 11-26.
4. Foidart JM, Beliard A & Donnez J 1993 In Endometriosis and Invasion. Current Status of Endometriosis. Research and Management, pp 35-39. Eds I Brosens & J Donnez. New York: Parthenon Publishing Group.
5. Frixen UH, Behrens J, Sachs M, Eberle G, Voss B, Warda A, Lochner D & Birchmeier W 1991 E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. Journal of Cell Biology 113 173-185.
6. Gaetje R, Kotzian S, Herrmann G, Baumann R & Starzinski-Powitz A 1997 Nonmalignant epithelial cells, potentially invasive in human endometriosis, lack the tumor suppressor molecule E-cadherin. American Journal of Pathology 150 461-467.
7. Giroldi LA, Bringuier PP, de Weijert M, Jansen C, van Bokhoven A & Schalken JA 1997 Role of E boxes in the repression of E-cadherin expression. Biochemical and Biophysical Research Communications 241 453-458.
8. Huiping C, Kristjansdottir S, Jonasson JG, Magnusson J, Egilsson V & Ingvarsson S 2001 Alterations of E-cadherin and β-catenin in gastric cancer. BMC Cancer 1 16.
9. Jonsson BA, Adami HO, Hagglund M, Bergh A, Goransson I, Stattin P, Wiklund F & Gronberg H 2004 - 160C/A polymorphism in the E-cadherin gene promoter and risk of hereditary, familial and sporadic prostate cancer. International Journal of Cancer 109 348-352.
10. Keirsebilck A, Van Hoorde L, Gao Y, De Bruyne G, Bruyneel E, Vermassen P, Mareel M & van Roy F 1998 Mechanisms of down-regulation of transfected E-cadherin cDNA during formation of invasive tumors in syngeneic mice. Invasion and Metastasis 18 44-56.
11. Li LC, Chui RM, Sasaki M, Nakajima K, Perinchery G, Au HC, Nojima D, Carroll P & Dahiya R 2002 A single nucleotide polymorphism in the E-cadherin gene promoter alters transcriptional activities. Cancer Research 60 873-876.
12. Lin HJ, Tsai FJ, Hung P, Chen WC, Chen HY, Fan SS & Tsai SW 2006 Association of E-cadherin gene 3′-UTR C/T polymorphism with primary open angle glaucoma. Ophthalmic Research 38 44-48.
13. Miller SA, Dybes DD & Polesky HF 1988 A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Research 16 1215.
14. Nakamura A, Shimazaki T, Kaneko K, Shibata M, Matsumura T, Nagai M, Makino R & Mitamura K 2002 Characterization of DNA polymorphisms in the E-cadherin gene (CDH1) promoter region. Mutation Research 502 19-24.
15. Park WS, Cho YG, Park JY, Kim CJ, Lee JH, Kim HS, Lee JW, Song YH, Park CH, Park YK et al. 2003 A single nucleotide polymorphism in the E-cadherin gene promoter-160 is not associated with risk of Korean gastric cancer. Journal of Korean Medical Science 18 501-504.
16. Poncelet C, Leblanc M, Walker-Combrouze F, Soriano D, Feldmann G, Madelenat P, Scoazec JY & Darai E 2002 Expression of cadherins and CD44 isoforms in human endometrium and peritoneal endometriosis. Acta Obstetricia et Gynecologica Scandinavica 81 195-203.
17. Scotti S, Regidor PA, Schindler AE & Winterhager E 2000 Reduced proliferation and cell adhesion in endometriosis. Molecular Human Reproduction 6 610-617.
18. Shimoyama Y, Hirohashi S, Hirano S, Noguchi M, Shimosato Y, Takeichi M & Abe O 1989 Cadherin cell-adhesion molecules in human epithelial tissues and carcinomas. Cancer Research 49 2128-2133.
19. Shin Y, Kim IJ, Kang HC, Park JH, Park HR, Park HW, Park MA, Lee JS, Yoon KA, Ku JL et al. 2004a The E-cadherin -347G → GA promoter polymorphism and its effect on transcriptional regulation. Carcinogenesis 25 895-899.
20. Shin Y, Kim IJ, Kang HC, Park JH, Park HW, Jang SG, Lee MR, Jeong SY, Chang HJ, Ku JL. et al. 2004b A functional polymorphism (-347 G → GA) in the E-cadherin gene is associated with colorectal cancer. Carcinogenesis 25 2173-2176.
21. Spuijbroek MD, Dunselman GA, Menheere PP & Evers JL 1992 Early endometriosis invades the extracellular matrix. Fertility and Sterility 58 929-933.
22. Starzinski-Powitz A, Handrow-Metzmacher H & Kotzian S 1999 The putative role of cell adhesion molecules in endometriosis: Can we learn from tumour metastasis? Molecular Medicine Today 5 304-309.
23. Takeichi M 1987 Cadherins: A molecular family essential for selective cell-cell adhesion and animal morphogenesis. Trends in Genetics 3 213-217.
24. Takeichi M 1990 Cadherins: A molecular family important in selective cell-cell adhesion. Annual Review of Biochemistry 59 237-252.
25. Thomas EJ 1993 Endometriosis. BMJ 306 158-159.
26. Tsai FJ, Wu HC, Chen HY, Lu HF, Hsu CD & Chen WC 2003 Association of E-cadherin gene 3′-UTR C/T polymorphism with calcium oxalate stone disease. Urologia Internationalis 70 278-281.
27. Tsukino H, Kuroda Y, Imai H, Nakao H, Qiu D, Komiya Y, Inatomi H, Hamasaki T, Kohshi K, Osada Y et al. 2004 Lack of evidence for the association of E-cadherin gene polymorphism with increased risk or progression of prostate cancer. Urologia Internationalis 72 203-207.
28. Ulrich CM, Bigler J, Velicer CM, Greene EA, Farin FM & Potter JD 2000 Searching expressed sequence tag databases: Discovery and confirmation of a common polymorphism in the thymidylate synthase gene. Cancer Epidemiology Biomarkers and Prevention 9 1381-1385.
29. Verhage BA, van Houwelingen K, Ruijter TE, Kiemeney LA & Schalken JA 2002 Single-nucleotide polymorphism in the E-cadherin gene promoter modifies the risk of prostate cancer. International Journal of Cancer 100 683-685.
30. Wang J, Pitarque M & Ingelman-Sundberg M 2006 3′-UTR polymorphism in the human CYP2A6 gene affects mRNA stability and enzyme expression. Biochemical and Biophysical Research Communications 10 491-497.
31. Wheelock MJ & Johnson KR 2003 Cadherins as modulators of cellular phenotype. Annual Review of Cell and Developmental Biology 19 207-235.
32. Wu MS, Huang SP, Chang YT, Lin MT, Shun CT, Chang MC, Wang HP, Chen CJ & Lin JT 2002 Association of the - 160 C→ a promoter polymorphismE-cadherin. Cancer 94 1443-1448.
33. Wu HC, Lai MT, Wu CI, Chen HY, Wan L, Tsai FJ & Chen WC 2005 E-cadherin gene 3′-UTR C/T polymorphism is associated with prostate cancer. Urologia Internationalis 75 335-350.
34. Yoshida R, Kimura N, Harada Y & Ohuchi N 2001 The loss of E-cadherin, α- and β-catenin expression is associated with metastasis and poor prognosis in invasive breast cancer. International Journal of Oncology 18 513-520.